Keep abreast and updated with the latest news and events happening in Credo Diagnostics and the world around us.
Credo Diagnostics Receives Excellence in Diagnostic Innovation at MedTech World Asia Awards 2026
A milestone in our mission to bring advanced molecular diagnostics closer to patients and veterinary care. Credo Diagnostics Biomedical received the Excellence in Diagnostic Innovation award at the MedTech World
Expo Científica CTR 2026 Highlights
From August 10 to 12, Credo Diagnostics Biomedical participated in Expo Científica CTR 2026 in Guadalajara, Mexico, bringing together professionals from across the laboratory and healthcare community. Throughout the exhibition,
Celebrating 15 Years of Innovation: Extended Warranty Program
Since 2011, Credo Diagnostics Biomedical has been dedicated to advancing molecular diagnostics through innovative Point-of-Care testing solutions. Over the past 15 years, we have worked alongside healthcare professionals, laboratories, veterinary
Credo Preps MDx System, Multiplex Respiratory Test for US Launch
NEW YORK – Singapore-based Credo Diagnostics Biomedical is preparing to start US clinical trials fora new near-patient point-of-care molecular diagnostic system and multiplex respiratory test. The company intends to submit the instrument
Credo VitaPCR™ System Has Passed the CAP Proficiency Testing
Credo Diagnostics Biomedical Pte. Ltd. to uphold quality and demonstrate product performance as well as compare it with competing brands in the market. Our VitaPCR™ system has successfully passed the CAP (College
Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care
VitaPCR™ RT-PCR test reaches sensitivity and specificity close to 100% (99,3% and 94,7%, respectively). With this 1.2 kg device, the test is simple and fast, obtaining results in 20 min
